ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
+28.27%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$138M
AUM Growth
-$10.1M
Cap. Flow
+$14.2M
Cap. Flow %
10.33%
Top 10 Hldgs %
57.7%
Holding
51
New
15
Increased
8
Reduced
16
Closed
8

Top Buys

1
TSHA icon
Taysha Gene Therapies
TSHA
$12.1M
2
RYZB
RayzeBio, Inc. Common Stock
RYZB
$7.65M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
$2.8M
4
HLVX icon
HilleVax
HLVX
$2.79M
5
REPL icon
Replimune Group
REPL
$2.57M

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$5.17M
2
ARGX icon
argenx
ARGX
$4.9M
3
CLNN icon
Clene
CLNN
$3.73M
4
GHRS icon
GH Research
GHRS
$2.9M
5
ROIV icon
Roivant Sciences
ROIV
$2.22M

Sector Composition

1 Healthcare 99.88%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VSTM icon
26
Verastem
VSTM
$663M
$1.87M 1.25%
230,000
-70,000
-23% -$569K
ELVN icon
27
Enliven Therapeutics
ELVN
$1.19B
$1.42M 0.95%
103,600
-900
-0.9% -$12.3K
DYN icon
28
Dyne Therapeutics
DYN
$2.02B
$1.31M 0.88%
146,500
+73,500
+101% +$659K
KRON
29
DELISTED
Kronos Bio
KRON
$934K 0.63%
718,739
+403,739
+128% +$525K
ACRS icon
30
Aclaris Therapeutics
ACRS
$227M
$834K 0.56%
121,692
– –
BMEA icon
31
Biomea Fusion
BMEA
$114M
$550K 0.37%
39,935
-65
-0.2% -$894
IONS icon
32
Ionis Pharmaceuticals
IONS
$9.76B
$513K 0.34%
+11,300
New +$513K
ETNB icon
33
89bio
ETNB
$1.32B
$506K 0.34%
+32,800
New +$506K
LPTX icon
34
Leap Therapeutics
LPTX
$11.7M
$489K 0.33%
+354,166
New +$489K
RZLT icon
35
Rezolute
RZLT
$696M
$409K 0.27%
310,000
-63,400
-17% -$83.7K
CLRB icon
36
Cellectar Biosciences
CLRB
$15.9M
$320K 0.21%
+4,043
New +$320K
GPCR icon
37
Structure Therapeutics
GPCR
$1.27B
$252K 0.17%
+5,000
New +$252K
ANTX icon
38
AN2 Therapeutics
ANTX
$34.4M
$214K 0.14%
+13,300
New +$214K
MRNS
39
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$157K 0.11%
+19,500
New +$157K
MRSN icon
40
Mersana Therapeutics
MRSN
$34M
$127K 0.08%
+3,984
New +$127K
CBIO
41
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
$41.3K 0.03%
+275
New +$41.3K
NUVB.WS icon
42
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
$9.08K 0.01%
90,832
– –
ARGX icon
43
argenx
ARGX
$45.9B
– –
-12,568
Closed -$4.9M
ARWR icon
44
Arrowhead Research
ARWR
$4.02B
– –
-27,500
Closed -$981K
BCLI
45
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
– –
0
– –
CLNN icon
46
Clene
CLNN
$60.2M
– –
-212,042
Closed -$3.73M
GHRS icon
47
GH Research
GHRS
$874M
– –
-244,828
Closed -$2.9M
ROIV icon
48
Roivant Sciences
ROIV
$8.82B
– –
-220,000
Closed -$2.22M
SVRA icon
49
Savara
SVRA
$643M
– –
-198,139
Closed -$633K
MORF
50
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-17,500
Closed -$1M
1
2
3